Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ubiquitin-like ligase-substrate adaptor activity	KLHL2 PRAMEF9 PRAMEF15 PRAMEF26 PRAMEF27 PRAMEF11	3.30e-05	82	148	6	GO:1990756
GeneOntologyMolecularFunction	enzyme-substrate adaptor activity	KLHL2 PRAMEF9 PRAMEF15 PRAMEF26 PRAMEF27 PRAMEF11	7.57e-05	95	148	6	GO:0140767
GeneOntologyMolecularFunction	small GTPase binding	DOCK1 DOCK2 KNTC1 MYO5B DOCK9 TRIP11 DOCK5 RAB3GAP1 RABGGTA GOLGA4	1.44e-04	321	148	10	GO:0031267
GeneOntologyMolecularFunction	ATP-dependent activity	WAPL ERCC6 ATP7B MYO5B MYO7A ABCA12 DYNC2H1 ABCA13 NAIP IFIH1 DNAH12 MYH15 ASCC3 SNRNP200	1.95e-04	614	148	14	GO:0140657
GeneOntologyMolecularFunction	GTPase activator activity	DOCK1 DOCK2 TAGAP DOCK5 RAB3GAP1 DLC1 AGAP7P AGAP4 AGAP6	2.41e-04	279	148	9	GO:0005096
GeneOntologyMolecularFunction	RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity	NANOGP8 NANOG	3.24e-04	4	148	2	GO:0001010
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	DOCK1 DOCK2 TAGAP PLEKHG7 DOCK9 DOCK5 RGL1 RAB3GAP1	3.34e-04	231	148	8	GO:0005085
GeneOntologyMolecularFunction	GTPase binding	DOCK1 DOCK2 KNTC1 MYO5B DOCK9 TRIP11 DOCK5 RAB3GAP1 RABGGTA GOLGA4	3.61e-04	360	148	10	GO:0051020
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DOCK1 DOCK2 TAGAP PLEKHG7 DOCK9 DOCK5 RGL1 RAB3GAP1 DLC1 AGAP7P AGAP4 AGAP6	4.05e-04	507	148	12	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DOCK1 DOCK2 TAGAP PLEKHG7 DOCK9 DOCK5 RGL1 RAB3GAP1 DLC1 AGAP7P AGAP4 AGAP6	4.05e-04	507	148	12	GO:0030695
GeneOntologyMolecularFunction	ATP hydrolysis activity	ERCC6 ATP7B MYO5B ABCA12 DYNC2H1 ABCA13 NAIP IFIH1 DNAH12 ASCC3 SNRNP200	4.58e-04	441	148	11	GO:0016887
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ERCC6 DRG2 ATP7B MYO5B ABCA12 DYNC2H1 ABCA13 NAIP IFIH1 DNAH12 AGAP7P ASCC3 AGAP4 AGAP6 SNRNP200	6.52e-04	775	148	15	GO:0017111
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	PRAMEF15 PRAMEF26 PRAMEF27 PRAMEF11	7.37e-04	55	148	4	GO:0042974
GeneOntologyMolecularFunction	pyrophosphatase activity	ERCC6 DRG2 ATP7B MYO5B ABCA12 DYNC2H1 ABCA13 NAIP IFIH1 DNAH12 AGAP7P ASCC3 AGAP4 AGAP6 SNRNP200	1.44e-03	839	148	15	GO:0016462
GeneOntologyMolecularFunction	transcription factor binding	NANOGP8 ZNF618 NANOG PRAMEF15 BBS2 CGGBP1 NCAPG2 ZFPM2 ZNF644 TAF4B PRAMEF26 PRAMEF27 PRAMEF11 CREB3	1.45e-03	753	148	14	GO:0008134
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ERCC6 DRG2 ATP7B MYO5B ABCA12 DYNC2H1 ABCA13 NAIP IFIH1 DNAH12 AGAP7P ASCC3 AGAP4 AGAP6 SNRNP200	1.46e-03	840	148	15	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ERCC6 DRG2 ATP7B MYO5B ABCA12 DYNC2H1 ABCA13 NAIP IFIH1 DNAH12 AGAP7P ASCC3 AGAP4 AGAP6 SNRNP200	1.46e-03	840	148	15	GO:0016818
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO5B MYO7A DYNC2H1 DNAH12 MYH15	1.87e-03	118	148	5	GO:0003774
GeneOntologyCellularComponent	Cul2-RING ubiquitin ligase complex	PRAMEF9 PRAMEF15 PRAMEF26 PRAMEF27 PRAMEF11	1.82e-05	47	145	5	GO:0031462
Domain	DHR-1_domain	DOCK1 DOCK2 DOCK9 DOCK5	1.07e-06	11	144	4	IPR027007
Domain	DHR_2	DOCK1 DOCK2 DOCK9 DOCK5	1.07e-06	11	144	4	PS51651
Domain	DHR_1	DOCK1 DOCK2 DOCK9 DOCK5	1.07e-06	11	144	4	PS51650
Domain	DHR-2	DOCK1 DOCK2 DOCK9 DOCK5	1.07e-06	11	144	4	PF06920
Domain	DOCK	DOCK1 DOCK2 DOCK9 DOCK5	1.07e-06	11	144	4	IPR026791
Domain	DOCK_C	DOCK1 DOCK2 DOCK9 DOCK5	1.07e-06	11	144	4	IPR010703
Domain	DOCK-C2	DOCK1 DOCK2 DOCK9 DOCK5	1.07e-06	11	144	4	PF14429
Domain	DHR-2	DOCK1 DOCK2 DOCK9 DOCK5	1.07e-06	11	144	4	IPR027357
Domain	DOCK_N	DOCK1 DOCK2 DOCK5	4.44e-06	5	144	3	PF16172
Domain	DOCK_N	DOCK1 DOCK2 DOCK5	4.44e-06	5	144	3	IPR032376
Domain	DUF4599	SPATA31D4 SPATA31D1 SPATA31D3	9.38e-05	12	144	3	PF15371
Domain	DUF4599	SPATA31D4 SPATA31D1 SPATA31D3	9.38e-05	12	144	3	IPR027970
Domain	AAA	ABCA12 DYNC2H1 ABCA13 NAIP DNAH12 ASCC3 SNRNP200	1.28e-04	144	144	7	SM00382
Domain	AAA+_ATPase	ABCA12 DYNC2H1 ABCA13 NAIP DNAH12 ASCC3 SNRNP200	1.28e-04	144	144	7	IPR003593
Domain	ARM-type_fold	DOCK1 DOCK2 SMG1 WAPL INTS7 DOCK9 NCAPG2 PPP4R4 DOCK5 HEATR6	3.04e-04	339	144	10	IPR016024
Domain	Sec63	ASCC3 SNRNP200	3.51e-04	4	144	2	PF02889
Domain	Sec63	ASCC3 SNRNP200	3.51e-04	4	144	2	SM00973
Domain	Sec63-dom	ASCC3 SNRNP200	3.51e-04	4	144	2	IPR004179
Domain	PRAME_family	PRAMEF25 PRAMEF15 PRAMEF27	3.97e-04	19	144	3	IPR026271
Domain	BAGE	BAGE2 BAGE3	5.81e-04	5	144	2	IPR012530
Domain	BAGE	BAGE2 BAGE3	5.81e-04	5	144	2	PF08180
Domain	Autophagy-rel_C	ATG2B VPS13B	5.81e-04	5	144	2	IPR015412
Domain	ATG_C	ATG2B VPS13B	5.81e-04	5	144	2	PF09333
Domain	ANK	ANKRD20A2P ANKRD20A3P KANK1 ANKRD20A4P AGAP7P AGAP4 AGAP6 ANKRD20A1	7.45e-04	251	144	8	SM00248
Domain	ANK_REPEAT	ANKRD20A2P ANKRD20A3P KANK1 ANKRD20A4P AGAP7P AGAP4 AGAP6 ANKRD20A1	7.84e-04	253	144	8	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKRD20A2P ANKRD20A3P KANK1 ANKRD20A4P AGAP7P AGAP4 AGAP6 ANKRD20A1	8.04e-04	254	144	8	IPR020683
Domain	ANK_REP_REGION	ANKRD20A2P ANKRD20A3P KANK1 ANKRD20A4P AGAP7P AGAP4 AGAP6 ANKRD20A1	8.04e-04	254	144	8	PS50297
Domain	FG-GAP	BBS2 ITGA2 ITGAD	8.07e-04	24	144	3	PF01839
Domain	FG-GAP	BBS2 ITGA2 ITGAD	8.07e-04	24	144	3	IPR013517
Domain	Ankyrin_rpt	ANKRD20A2P ANKRD20A3P KANK1 ANKRD20A4P AGAP7P AGAP4 AGAP6 ANKRD20A1	9.83e-04	262	144	8	IPR002110
Domain	Ank_2	ANKRD20A2P ANKRD20A3P KANK1 ANKRD20A4P AGAP4 AGAP6 ANKRD20A1	1.41e-03	215	144	7	PF12796
Domain	ArfGap	AGAP7P AGAP4 AGAP6	1.42e-03	29	144	3	SM00105
Domain	ARFGAP	AGAP7P AGAP4 AGAP6	1.42e-03	29	144	3	PS50115
Domain	ArfGap	AGAP7P AGAP4 AGAP6	1.42e-03	29	144	3	PF01412
Domain	ArfGAP	AGAP7P AGAP4 AGAP6	1.42e-03	29	144	3	IPR001164
Domain	Chorein_N	ATG2B VPS13B	1.60e-03	8	144	2	PF12624
Domain	VPS13_N	ATG2B VPS13B	1.60e-03	8	144	2	IPR026854
Domain	Ank	ANKRD20A2P ANKRD20A3P KANK1 ANKRD20A4P AGAP7P AGAP4 ANKRD20A1	1.97e-03	228	144	7	PF00023
Domain	HEAT_REPEAT	SMG1 NCAPG2 PPP4R4 HEATR6	2.10e-03	70	144	4	PS50077
Domain	Myosin_head_motor_dom	MYO5B MYO7A MYH15	3.11e-03	38	144	3	IPR001609
Domain	MYOSIN_MOTOR	MYO5B MYO7A MYH15	3.11e-03	38	144	3	PS51456
Domain	Myosin_head	MYO5B MYO7A MYH15	3.11e-03	38	144	3	PF00063
Domain	MYSc	MYO5B MYO7A MYH15	3.11e-03	38	144	3	SM00242
Domain	-	ANKRD20A2P ANKRD20A3P KANK1 ANKRD20A4P AGAP4 AGAP6 ANKRD20A1	3.15e-03	248	144	7	1.25.40.20
Domain	ABC_A	ABCA12 ABCA13	3.70e-03	12	144	2	IPR026082
Domain	GRIP_dom	TRIP11 GOLGA4	3.70e-03	12	144	2	IPR000237
Domain	GRIP	TRIP11 GOLGA4	3.70e-03	12	144	2	PS50913
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH12	5.06e-03	14	144	2	IPR024317
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH12	5.06e-03	14	144	2	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH12	5.06e-03	14	144	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DNAH12	5.06e-03	14	144	2	IPR011704
Domain	AAA_8	DYNC2H1 DNAH12	5.06e-03	14	144	2	PF12780
Domain	AAA_5	DYNC2H1 DNAH12	5.06e-03	14	144	2	PF07728
Domain	DHC_fam	DYNC2H1 DNAH12	5.80e-03	15	144	2	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH12	5.80e-03	15	144	2	PF03028
Domain	Dynein_heavy_dom	DYNC2H1 DNAH12	5.80e-03	15	144	2	IPR004273
Domain	P-loop_NTPase	ERCC6 DRG2 MYO5B MYO7A ABCA12 DYNC2H1 ABCA13 APAF1 NAIP IFIH1 DNAH12 MYH15 ASCC3 SNRNP200	5.94e-03	848	144	14	IPR027417
Domain	Integrin_alpha_C_CS	ITGA2 ITGAD	6.60e-03	16	144	2	IPR018184
Pubmed	Expression of testicular germ cell genes identified by differential display analysis.	ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	2.49e-08	8	153	4	12634303
Pubmed	Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.	DOCK1 DOCK2 DOCK9 DOCK5	3.48e-07	14	153	4	12432077
Pubmed	The Rac-specific exchange factors Dock1 and Dock5 are dispensable for the establishment of the glomerular filtration barrier in vivo.	DOCK1 DOCK2 DOCK5	8.29e-07	5	153	3	24365888
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	PPP1R21 CASP8AP2 WAPL INTS7 DYNC2H1 NUP210L BBS2 TRIP11 DOCK5 BSG CPSF1 ASTN1 SNRNP200 GOLGB1 MAP3K19	1.34e-06	754	153	15	35906200
Pubmed	Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.	PRAMEF15 PRAMEF26 PRAMEF27 PRAMEF11	2.48e-06	22	153	4	31729367
Pubmed	MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.	PRAMEF15 PRAMEF26 PRAMEF27 PRAMEF11	4.24e-06	25	153	4	37451217
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF15 PRAMEF26 PRAMEF27 PRAMEF11	6.79e-06	28	153	4	25089626
Pubmed	GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins.	AGAP7P AGAP4 AGAP6	6.88e-06	9	153	3	12640130
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CASP8AP2 DRG2 DYNC2H1 PPFIBP1 APAF1 CCDC18 BBS2 NCAPG2 ADD2 DNAJC2 RAB3GAP1 DNAJC10 BSG ZNF644 ASCC3 SNRNP200 VPS13B GOLGA4 GOLGB1 NIN	9.00e-06	1487	153	20	33957083
Pubmed	AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.	AGAP7P AGAP4 AGAP6	9.79e-06	10	153	3	20664521
Pubmed	AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase.	AGAP7P AGAP4 AGAP6	1.34e-05	11	153	3	15381706
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	FLT1 WAPL ERCC6 MYO7A DOCK9 IFIH1 DNAH12 DNAJC10 BSG CPSF1 ASCC3	1.37e-05	497	153	11	36774506
Pubmed	Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.	PRAMEF15 PRAMEF26 PRAMEF27 PRAMEF11	1.70e-05	35	153	4	19389355
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	ERCC6 MYO7A ABCA12 ABCA13 ATG2B DOCK5 CPSF1 AGAP7P AGAP4 SNRNP200 RABGGTA	1.84e-05	513	153	11	25798074
Pubmed	Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer.	IL1B IL4	1.92e-05	2	153	2	15900573
Pubmed	The Effects of Armillarisin A on Serum IL-1β and IL-4 and in Treating Ulcerative Colitis.	IL1B IL4	1.92e-05	2	153	2	25420534
Pubmed	Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1.	DOCK1 DOCK2	1.92e-05	2	153	2	28467910
Pubmed	Functional evidence that the self-renewal gene NANOG regulates human tumor development.	NANOGP8 NANOG	1.92e-05	2	153	2	19415763
Pubmed	DOCK2 and DOCK5 act additively in neutrophils to regulate chemotaxis, superoxide production, and extracellular trap formation.	DOCK2 DOCK5	1.92e-05	2	153	2	25339677
Pubmed	The involvement of interleukin-1 and interleukin-4 in the response of human annulus fibrosus cells to cyclic tensile strain: an altered mechanotransduction pathway with degeneration.	IL1B IL4	1.92e-05	2	153	2	21276216
Pubmed	Hydrogen sulfide upregulates glutamate-cysteine ligase catalytic subunit, glutamate-cysteine ligase modifier subunit, and glutathione and inhibits interleukin-1β secretion in monocytes exposed to high glucose levels.	GCLC IL1B	1.92e-05	2	153	2	24665821
Pubmed	Integrity of ATP binding site is essential for effective inhibition of the intrinsic apoptosis pathway by NAIP.	APAF1 NAIP	1.92e-05	2	153	2	21371431
Pubmed	Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production.	KLRB1 IL4	1.92e-05	2	153	2	9130646
Pubmed	The role of circulating cytokines and thyroid hormones in the development of the nephrotic variant of glomerulonephritis.	IL1B IL4	1.92e-05	2	153	2	29244911
Pubmed	Association of Interleukin-1B and Interleukin-4 Gene Variants with Autoimmune Thyroid Diseases in Tunisian Population.	IL1B IL4	1.92e-05	2	153	2	27100882
Pubmed	CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses.	CD81 IL4	1.92e-05	2	153	2	9482907
Pubmed	Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species.	NANOGP8 NANOG	1.92e-05	2	153	2	24598770
Pubmed	Differential expression of nanog1 and nanogp8 in colon cancer cells.	NANOGP8 NANOG	1.92e-05	2	153	2	22079639
Pubmed	A role for the Golgi matrix protein giantin in ciliogenesis through control of the localization of dynein-2.	DYNC2H1 GOLGB1	1.92e-05	2	153	2	24046448
Pubmed	Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.	NANOGP8 NANOG	1.92e-05	2	153	2	21136380
Pubmed	Association of IL1β and IL4 gene polymorphisms with nasal polyps in a Polish population.	IL1B IL4	1.92e-05	2	153	2	24668571
Pubmed	Interleukin-1β (IL-1β) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE.	IL1B IL4	1.92e-05	2	153	2	27488002
Pubmed	The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin.	AGAP7P AGAP4 AGAP6	2.31e-05	13	153	3	27713690
Pubmed	The Arf family GTPase Arl4A complexes with ELMO proteins to promote actin cytoskeleton remodeling and reveals a versatile Ras-binding domain in the ELMO proteins family.	DOCK1 DOCK2 DOCK5	2.31e-05	13	153	3	21930703
Pubmed	GTP-binding protein-like domain of AGAP1 is protein binding site that allosterically regulates ArfGAP protein catalytic activity.	AGAP7P AGAP4 AGAP6	2.93e-05	14	153	3	22453919
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	DOCK1 KNTC1 ICE1 DOCK5 HEATR6 ASCC3 SNRNP200	3.33e-05	202	153	7	33005030
Pubmed	Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins.	TMEM120B WAPL APAF1 NIT2 DNAJC10	3.60e-05	84	153	5	34159380
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	DOCK1 PPP1R21 ATP7B VPS54 DNAJC10 AFF1 GOLGA4 WDFY1	4.09e-05	285	153	8	34369648
Pubmed	Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells.	NANOGP8 NANOG PRAMEF15 PRAMEF11	5.09e-05	46	153	4	17287250
Pubmed	The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1.	NANOGP8 NANOG	5.75e-05	3	153	2	30814124
Pubmed	Multiple phases in regulation of Nanog expression during pre-implantation development.	NANOGP8 NANOG	5.75e-05	3	153	2	26660234
Pubmed	Interleukin-4 induces a CD44high /CD49bhigh PC3 subpopulation with tumor-initiating characteristics.	ITGA2 IL4	5.75e-05	3	153	2	29236307
Pubmed	Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog.	NANOGP8 NANOG	5.75e-05	3	153	2	18177668
Pubmed	Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma.	IL1B IL4	5.75e-05	3	153	2	26674732
Pubmed	Role of DOCK2 and DOCK180 in fetal thymus colonization.	DOCK1 DOCK2	5.75e-05	3	153	2	19728314
Pubmed	Nanog co-regulated by Nodal/Smad2 and Oct4 is required for pluripotency in developing mouse epiblast.	NANOGP8 NANOG	5.75e-05	3	153	2	24929238
Pubmed	Nanog and transcriptional networks in embryonic stem cell pluripotency.	NANOGP8 NANOG	5.75e-05	3	153	2	17211451
Pubmed	The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus.	NANOGP8 NANOG	5.75e-05	3	153	2	15502159
Pubmed	Nanog variability and pluripotency regulation of embryonic stem cells--insights from a mathematical model analysis.	NANOGP8 NANOG	5.75e-05	3	153	2	20574542
Pubmed	lincRNAs act in the circuitry controlling pluripotency and differentiation.	NANOGP8 NANOG	5.75e-05	3	153	2	21874018
Pubmed	Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations.	NANOGP8 NANOG	5.75e-05	3	153	2	23054952
Pubmed	CrxOS maintains the self-renewal capacity of murine embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	19800316
Pubmed	Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog.	NANOGP8 NANOG	5.75e-05	3	153	2	26975336
Pubmed	Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3.	NANOGP8 NANOG	5.75e-05	3	153	2	23329853
Pubmed	Genome-wide chromatin interactions of the Nanog locus in pluripotency, differentiation, and reprogramming.	NANOGP8 NANOG	5.75e-05	3	153	2	23665121
Pubmed	Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts.	NANOGP8 NANOG	5.75e-05	3	153	2	26733157
Pubmed	Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features.	NANOGP8 NANOG	5.75e-05	3	153	2	16501172
Pubmed	Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	19582141
Pubmed	Nanog is the gateway to the pluripotent ground state.	NANOGP8 NANOG	5.75e-05	3	153	2	19703398
Pubmed	Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology.	NANOGP8 NANOG	5.75e-05	3	153	2	28636920
Pubmed	A distinct expression pattern in mammalian testes indicates a conserved role for NANOG in spermatogenesis.	NANOGP8 NANOG	5.75e-05	3	153	2	20539761
Pubmed	Genetic polymorphisms of ACE I/D, IL-1β G > A and IL-4 VNTR among Egyptian subjects with rheumatoid arthritis.	IL1B IL4	5.75e-05	3	153	2	31830807
Pubmed	Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.	NANOGP8 NANOG	5.75e-05	3	153	2	18584034
Pubmed	Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	21969378
Pubmed	The phosphoinositide-3-kinase/Akt pathway mediates the transient increase in Nanog expression during differentiation of F9 cells.	NANOGP8 NANOG	5.75e-05	3	153	2	20661723
Pubmed	NANOG restores the impaired myogenic differentiation potential of skeletal myoblasts after multiple population doublings.	NANOGP8 NANOG	5.75e-05	3	153	2	29245050
Pubmed	Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation.	NANOGP8 NANOG	5.75e-05	3	153	2	15494369
Pubmed	Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog.	NANOGP8 NANOG	5.75e-05	3	153	2	14728807
Pubmed	Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions.	NANOGP8 NANOG	5.75e-05	3	153	2	21194951
Pubmed	Identification and regulation of a stage-specific stem cell niche enriched by Nanog-positive spermatogonial stem cells in the mouse testis.	NANOGP8 NANOG	5.75e-05	3	153	2	22388986
Pubmed	Nanog promotes transfer of pluripotency after cell fusion.	NANOGP8 NANOG	5.75e-05	3	153	2	16791199
Pubmed	Mammalian cells express three distinct dynein heavy chains that are localized to different cytoplasmic organelles.	DYNC2H1 DNAH12	5.75e-05	3	153	2	8666668
Pubmed	Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	18024963
Pubmed	The pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	27125671
Pubmed	Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	25410303
Pubmed	Genome editing demonstrates that the -5 kb Nanog enhancer regulates Nanog expression by modulating RNAPII initiation and/or recruitment.	NANOGP8 NANOG	5.75e-05	3	153	2	33334884
Pubmed	Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder.	NANOGP8 NANOG	5.75e-05	3	153	2	17360937
Pubmed	Nanog dynamics in single embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	26760119
Pubmed	Nanog is dispensable for the generation of induced pluripotent stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	24461999
Pubmed	Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing.	NANOGP8 NANOG	5.75e-05	3	153	2	30837263
Pubmed	Nanog induces hyperplasia without initiating tumors.	NANOGP8 NANOG	5.75e-05	3	153	2	25173648
Pubmed	Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function.	NANOGP8 NANOG	5.75e-05	3	153	2	27939294
Pubmed	Identification of genes regulated by nanog which is involved in ES cells pluripotency and early differentiation.	NANOGP8 NANOG	5.75e-05	3	153	2	18442017
Pubmed	DOCK5 functions as a key signaling adaptor that links FcεRI signals to microtubule dynamics during mast cell degranulation.	DOCK2 DOCK5	5.75e-05	3	153	2	24913231
Pubmed	[Genetic polymorphism of cytokines IL-1β, IL-4 and TNF-α as a factor modifying the impact of childhood adversity on schizophrenia symptoms].	IL1B IL4	5.75e-05	3	153	2	36168695
Pubmed	A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal.	NANOGP8 NANOG	5.75e-05	3	153	2	16790525
Pubmed	DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis.	DOCK2 DOCK5	5.75e-05	3	153	2	36804596
Pubmed	Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling.	NANOGP8 NANOG	5.75e-05	3	153	2	22172669
Pubmed	Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.	NANOGP8 NANOG	5.75e-05	3	153	2	19447925
Pubmed	The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	30846691
Pubmed	Generation of germline-competent induced pluripotent stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	17554338
Pubmed	VEGFR1 Signaling Regulates IL-4-Mediated Arginase 1 Expression in Macrophages.	FLT1 IL4	5.75e-05	3	153	2	29110610
Pubmed	Expression of Nanog gene promotes NIH3T3 cell proliferation.	NANOGP8 NANOG	5.75e-05	3	153	2	16259959
Pubmed	A novel NK-type homeobox gene, ENK (early embryo specific NK), preferentially expressed in embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	12609610
Pubmed	Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1.	NANOGP8 NANOG	5.75e-05	3	153	2	24227785
Pubmed	The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis.	NANOGP8 NANOG	5.75e-05	3	153	2	23770853
Pubmed	Nanog-independent reprogramming to iPSCs with canonical factors.	NANOGP8 NANOG	5.75e-05	3	153	2	24527385
Pubmed	Aromatic residues in the C-terminal domain 2 are required for Nanog to mediate LIF-independent self-renewal of mouse embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	18086680
Pubmed	Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	17204467
Pubmed	Chromatin decondensation and nuclear softening accompany Nanog downregulation in embryonic stem cells.	NANOGP8 NANOG	5.75e-05	3	153	2	23200040
Interaction	ANKRD20A4P interactions	ANKRD20A2P ANKRD20A4P ANKRD20A1	6.74e-06	6	142	3	int:ANKRD20A4P
Interaction	ANKRD20A2P interactions	ANKRD20A2P ANKRD20A4P ANKRD20A1	1.17e-05	7	142	3	int:ANKRD20A2P
Interaction	DYNLL2 interactions	CDR2 DYNC2H1 USP28 PPFIBP1 ANKRD20A2P KANK1 ANKRD20A4P PAXIP1 ANKRD20A1 GOLGB1	1.77e-05	263	142	10	int:DYNLL2
Cytoband	1p36.21	PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF26 PRAMEF11	2.32e-06	63	153	5	1p36.21
Cytoband	9q21.32	SPATA31D4 SPATA31D1 SPATA31D3	3.38e-05	19	153	3	9q21.32
Cytoband	10q11.23	ERCC6 AGAP7P AGAP6	1.84e-04	33	153	3	10q11.23
Cytoband	16p12.3	SMG1 CDR2 VPS35L	2.01e-04	34	153	3	16p12.3
Cytoband	Ensembl 112 genes in cytogenetic band chr9q21	ANKRD20A3P SPATA31D4 SPATA31D1 SPATA31D3 ANKRD20A1	5.66e-04	199	153	5	chr9q21
Cytoband	2q21.3	RAB3GAP1 MAP3K19	1.13e-03	15	153	2	2q21.3
GeneFamily	PRAME family	PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF26 PRAMEF27 PRAMEF11	2.54e-09	24	97	6	686
GeneFamily	X-linked mental retardation\|RNA helicases	IFIH1 ASCC3 SNRNP200	2.39e-05	11	97	3	1168
GeneFamily	Ankyrin repeat domain containing	ANKRD20A2P ANKRD20A3P KANK1 ANKRD20A4P AGAP7P AGAP4 AGAP6 ANKRD20A1	4.76e-05	242	97	8	403
GeneFamily	ArfGAPs	AGAP7P AGAP4 AGAP6	7.27e-04	33	97	3	395
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG7 DOCK9 PRKD3 AGAP7P AGAP4 AGAP6	8.50e-04	206	97	6	682
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ITGA2 ADGRE2 ITGAD CLEC12A BSG CD72 CD81 KLRB1	1.27e-03	394	97	8	471
GeneFamily	ATP binding cassette subfamily A	ABCA12 ABCA13	2.49e-03	14	97	2	805
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	AGAP4 AGAP6	3.68e-03	17	97	2	1291
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA2 ITGAD	4.12e-03	18	97	2	1160
GeneFamily	NKL subclass homeoboxes and pseudogenes	NANOGP8 NANOG HMX2	5.59e-03	67	97	3	519
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EYA4 DYNC2H1 ABCA13 PLEKHG7 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	9.57e-09	176	151	9	dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell	facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 ERCC6 DYNC2H1 NUP210L DCUN1D4 PAXIP1 FYB2 FDXACB1	1.24e-07	170	151	8	d70aaa0f4e5034bb9f61b832b5f9123870936d3c
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 FLT1 WAPL NUP210L ASH1L TRIP11 IFIH1 ASCC3	1.76e-07	178	151	8	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	ABCA13 PLEKHG7 SLC9C2 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	2.78e-07	189	151	8	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DYNC2H1 ABCA13 SLC9C2 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	3.01e-07	191	151	8	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 ABCA13 PLEKHG7 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	3.53e-07	195	151	8	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NLRP11 OR2G6 ITGAD PRKD3 DNAJC10 CD72 NIN	1.07e-06	156	151	7	203ef22eb76bd2b829b027c30af0557080f4006c
ToppCell	Ciliated_cells-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	DYNC2H1 CFAP54 DNAH12 SLC35D3 FYB2 CFAP46 MAP3K19	1.49e-06	164	151	7	fd30c55d0d75ef8b9396435d836187168095152b
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 ABCA12 ABCA13 LRP1B PKHD1L1 CNTN6 MYH15	1.82e-06	169	151	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	ABCA13 SLC9C2 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	2.98e-06	182	151	7	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	18-Airway-Epithelial-Multiciliated_precursor\|Airway / Age, Tissue, Lineage and Cell class	MYO5B CCDC18 CFAP54 DNAH12 ANKRD20A4P ANKRD20A1 CFAP46	3.09e-06	183	151	7	a75cda2131755931117c387f2e0ae3394efa8e80
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	ABCA13 SLC9C2 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	3.32e-06	185	151	7	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WAPL ASH1L ITGA2 TRIP11 GCLC GOLGA4 GOLGB1	3.57e-06	187	151	7	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	ABCA13 PLEKHG7 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	3.69e-06	188	151	7	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ABCA13 PLEKHG7 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	3.83e-06	189	151	7	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	ABCA13 PLEKHG7 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	3.83e-06	189	151	7	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	droplet-Marrow-nan-3m-Hematologic-erythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 EYA4 TMEM120B PKHD1L1 NCAPG2 ADD2 GCLC	3.83e-06	189	151	7	8a38baee58a27c2fa3f4bd131ab9f15723ed9295
ToppCell	COPD-Myeloid-cDC1\|COPD / Disease state, Lineage and Cell class	FLT1 APAF1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	4.24e-06	192	151	7	bd3d00b094d92463b06023361a71240851a542b8
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DYNC2H1 ABCA13 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	4.39e-06	193	151	7	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DYNC2H1 ABCA13 ITGA2 CFAP54 FYB2 CFAP46 MAP3K19	4.39e-06	193	151	7	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK2 KLHL2 MYO7A NAIP ADGRE2 RGL1 GCLC	4.54e-06	194	151	7	663e7e7fe48157e808b4f1a0ea6ad41944e857a2
ToppCell	Control-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DYNC2H1 ABCA13 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	4.54e-06	194	151	7	958e648138676d46698090b4046cb484083ae449
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 DYNC2H1 ASH1L TRIP11 ASCC3 GOLGA4 GOLGB1	4.70e-06	195	151	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	INTS7 DCUN1D4 DOCK5 KANK1 TDRD6 ANKRD20A1	4.79e-06	127	151	6	9071cd0953c8bb6746dc9cd13d153e3d6ef40b08
ToppCell	BL\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DOCK2 TAGAP NAIP ADGRE2 CLEC12A IL1B NIN	5.02e-06	197	151	7	1acf0191fa0a25cd20bfd9ea7bf727a1555986a1
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 PLEKHG7 DNAH12 GCLC GOLGB1 CFAP46 MAP3K19	5.19e-06	198	151	7	d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 ASH1L ZNF644 SNRNP200 VPS13B GOLGA4 GOLGB1	5.37e-06	199	151	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 PLEKHG7 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	5.37e-06	199	151	7	2498237b9e895ca4826a3378d9d40989968df72b
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 PLEKHG7 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	5.37e-06	199	151	7	542ec45c931b40738df1f3777b00c83be33a514a
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 PLEKHG7 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	5.55e-06	200	151	7	926a7ea94b5908aebf103893ea83ce9d25285b65
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 PLEKHG7 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	5.55e-06	200	151	7	06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 MYO7A TAGAP NAIP ADGRE2 CD72 IL1B	5.55e-06	200	151	7	27f498bcd706d0751091662996795b5270e46f14
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 LRP1B PKHD1L1 ASTN1 MYH15 TDRD6	1.79e-05	160	151	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 LRP1B PKHD1L1 ASTN1 MYH15 TDRD6	1.79e-05	160	151	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	2.44e-05	169	151	6	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 ABCA13 PLEKHG7 CFAP54 DNAH12 CFAP46	2.44e-05	169	151	6	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EYA4 ABCA12 ABCA13 PLEKHG7 FER1L6 FYB2	2.61e-05	171	151	6	25c1979e972c959e1ce4c57804f976f53a247ad7
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EYA4 ABCA12 ABCA13 PLEKHG7 FER1L6 FYB2	2.61e-05	171	151	6	fe27bf581c75ef33c2848878e51ed16b275a4c8e
ToppCell	Ciliated_cells-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	DYNC2H1 ABCA13 CFAP54 DNAH12 FYB2 MAP3K19	2.69e-05	172	151	6	187ae91148d293537afc77e10da2b64302322224
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANKRD20A3P CLEC12A PPP4R4 PTPRO GCLC ANKRD20A1	2.78e-05	173	151	6	d13ae4046a25ee0fb492ddedf44583a879a432e9
ToppCell	Basal_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ABCA13 ANKRD20A2P ANKRD20A3P ANKRD20A4P TDRD6 FYB2	2.87e-05	174	151	6	a0060be3940043015dcc49a5157de5541aed24a1
ToppCell	facs-Trachea-3m-Hematologic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DOCK2 TAGAP CLEC12A PTPRO CD72 IL1B	3.16e-05	177	151	6	c9d235fc518b291ed98088a1206d14d6692bc7fd
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SLC9C2 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	3.26e-05	178	151	6	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMG1 EYA4 ATP7B ABCA13 FER1L6 GOLGB1	3.37e-05	179	151	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DOCK2 HIVEP2 KIZ ITGA2 ZFPM2 RGL1	3.37e-05	179	151	6	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLEKHG7 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	3.58e-05	181	151	6	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ATG2B HECTD4 ANKRD20A4P GCLC BSG ANKRD20A1	3.70e-05	182	151	6	93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DOCK2 HIVEP2 KIZ ITGA2 ZFPM2 RGL1	3.70e-05	182	151	6	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	COPD-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	APAF1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	3.93e-05	184	151	6	42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94
ToppCell	5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NAIP ADGRE2 CLEC12A RGL1 CD72 IL1B	3.93e-05	184	151	6	ba260f8a2e6e510141a6b9c458eb0040acff0352
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA13 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	3.93e-05	184	151	6	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	Ciliated_cells-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	ABCA13 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	4.05e-05	185	151	6	4fc7113d3dadc716ec5a8e62b58543cc00ce5b16
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DYNC2H1 PLEKHG7 CFAP54 DNAH12 CFAP46 MAP3K19	4.05e-05	185	151	6	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	PLEKHG7 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	4.05e-05	185	151	6	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	Control-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	FLT1 PPFIBP1 DOCK9 ANKRD20A2P ANKRD20A3P ZFPM2	4.05e-05	185	151	6	a28187c2fd23564314b35759479ff2ca21f61485
ToppCell	IPF-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	APAF1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	4.17e-05	186	151	6	962c2dada19185628ead77c32fcb07fa95114247
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells-Pro-B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KLHL2 TAGAP ADGRE2 GZMK CD72 IL1B	4.17e-05	186	151	6	4a5264e32ba004ed58dc4102d84e4bc4dbbe1440
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KLHL2 TAGAP ADGRE2 GZMK CD72 IL1B	4.17e-05	186	151	6	528ee88f6e27863c7bcdffd4416cbbd83fc65e9d
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	SMG1 CASP8AP2 WAPL RAB3GAP1 ZNF644 VPS13B	4.17e-05	186	151	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLEKHG7 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	4.30e-05	187	151	6	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	Control-Endothelial-VE_Capillary_A\|Control / Disease state, Lineage and Cell class	FLT1 PPFIBP1 DOCK9 ANKRD20A2P ANKRD20A3P ZFPM2	4.30e-05	187	151	6	54d7588172ac145ff5045ad9771636729ca3f0ca
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	ABCA13 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	4.43e-05	188	151	6	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA13 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	4.43e-05	188	151	6	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	IPF-Myeloid-cDC1\|IPF / Disease state, Lineage and Cell class	APAF1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	4.43e-05	188	151	6	2331a2bae1383820d598e93aa86c75b101069bac
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA13 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	4.56e-05	189	151	6	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	PLEKHG7 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	4.56e-05	189	151	6	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM120B WAPL PKHD1L1 NCAPG2 ADD2 GCLC	4.56e-05	189	151	6	16dfc37d8d390ed7f927bc844c47c9c5a89a0928
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM120B WAPL PKHD1L1 NCAPG2 ADD2 GCLC	4.56e-05	189	151	6	3ade3fa9369e85304b20d7233b581f18ad5ecc89
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DYNC2H1 ABCA13 CFAP54 DNAH12 FYB2 CFAP46	4.56e-05	189	151	6	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 CDR2 ABCA13 PPFIBP1 KANK1 CFAP54	4.84e-05	191	151	6	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA13 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	4.84e-05	191	151	6	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA13 SLC9C2 CFAP54 DNAH12 CFAP46 MAP3K19	4.84e-05	191	151	6	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	COPD-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	APAF1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	4.84e-05	191	151	6	3480e6d27dd4291765bbbb2acdb6a2e4f02c8085
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DYNC2H1 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	4.98e-05	192	151	6	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	DYNC2H1 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	4.98e-05	192	151	6	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	COVID-19-kidney-Myeloid\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK2 KLHL2 ADGRE2 CLEC12A DOCK5 IL1B	4.98e-05	192	151	6	0b9d22a222f1201e375f8e55cace9ef939febae4
ToppCell	Bronchial_Brush\|World / Tissue, Lineage and Cell class of Lung Cells from 10X	DYNC2H1 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	5.12e-05	193	151	6	3e693ac4c92576e3f2c9efdd3f1d96d3d336e260
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 ABCA13 CFAP54 DNAH12 CFAP46 MAP3K19	5.12e-05	193	151	6	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ABCA13 CFAP54 DNAH12 FYB2 CFAP46 MAP3K19	5.27e-05	194	151	6	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EYA4 ABCA13 PLEKHG7 CREB3L4 FER1L6 FAM222A	5.27e-05	194	151	6	e0228f593c3493175962a4817500d4337ddc4e88
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 WAPL ASH1L TRIP11 ASCC3 WDFY1	5.27e-05	194	151	6	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 ABCA13 CFAP54 DNAH12 CFAP46 MAP3K19	5.27e-05	194	151	6	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 DYNC2H1 ASH1L ASCC3 GOLGA4 GOLGB1	5.43e-05	195	151	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Children_(3_yrs)-Immune-monocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK2 KLHL2 NAIP ADGRE2 CLEC12A DOCK5	5.58e-05	196	151	6	cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	MYO5B DYNC2H1 CFAP54 DNAH12 FYB2 CFAP46	5.58e-05	196	151	6	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 SLC9C2 CFAP54 DNAH12 FYB2 CFAP46	5.74e-05	197	151	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Bronchus_Control_(B.)\|World / Sample group, Lineage and Cell type	EYA4 HIVEP2 ABCA13 ITGA2 FAM222A GOLGB1	5.74e-05	197	151	6	b6dff2ee108813e18657e2d8cf850e2423f8c8e9
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EYA4 ABCA12 ABCA13 PLEKHG7 ITGA2 GCLC	5.91e-05	198	151	6	19d8ff3a4f911b13ecc34844202925475ad4d2ab
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA13 PLEKHG7 DNAH12 FYB2 CFAP46 MAP3K19	6.07e-05	199	151	6	1ee4010d8557564e25e8ee00b914c2dfd9037838
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA13 PLEKHG7 DNAH12 FYB2 CFAP46 MAP3K19	6.07e-05	199	151	6	74087b4b5e567310fc4ac58fb267ff651a180680
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	PPFIBP1 KIZ TRIP11 ZNF644 GOLGA4 GOLGB1	6.07e-05	199	151	6	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 FLT1 PPFIBP1 ZFPM2 DLC1 BSG	6.24e-05	200	151	6	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 FLT1 PPFIBP1 ZFPM2 DLC1 BSG	6.24e-05	200	151	6	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 FLT1 PPFIBP1 ZFPM2 DLC1 BSG	6.24e-05	200	151	6	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 ASH1L IFIH1 ZNF644 GOLGA4 GOLGB1	6.24e-05	200	151	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 USP28 GZMK CD81 KLRB1 GOLGA4	6.24e-05	200	151	6	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 FLT1 PPFIBP1 ZFPM2 DLC1 BSG	6.24e-05	200	151	6	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 FLT1 PPFIBP1 ZFPM2 DLC1 BSG	6.24e-05	200	151	6	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_other\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 MYO7A NAIP ADGRE2 CD72 IL1B	6.24e-05	200	151	6	1438b84096de9b4abe9e6213caa07f6bdff67358
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 FLT1 PPFIBP1 ZFPM2 DLC1 BSG	6.24e-05	200	151	6	7136936d05ab344a560cf159684c881063b5430d
Drug	AC1L1DU2	DOCK1 DOCK9 DOCK5 IL4	2.94e-06	16	148	4	CID000002507
Disease	cerebral palsy (implicated_via_orthology)	ADD2 AGAP7P AGAP4 AGAP6	8.36e-08	10	134	4	DOID:1969 (implicated_via_orthology)
Disease	Psoriasis	TAGAP IFIH1 IL1B IL4	1.33e-04	57	134	4	C0033860
Disease	Pustulosis of Palms and Soles	TAGAP IFIH1 IL1B IL4	1.33e-04	57	134	4	C0030246
Disease	sensorineural hearing loss (is_implicated_in)	EYA4 MYO7A ITGA2	4.52e-04	33	134	3	DOID:10003 (is_implicated_in)
Disease	Leishmaniasis, Cutaneous	IL1B IL4	5.63e-04	8	134	2	C0023283
Disease	Urban cutaneous leishmaniasis	IL1B IL4	5.63e-04	8	134	2	C0086541
Disease	Leishmaniasis, New World	IL1B IL4	5.63e-04	8	134	2	C0086540
Disease	glycosyl-N-stearoyl-sphingosine (d18:1/18:0) measurement	CREB3L4 CREB3	7.22e-04	9	134	2	EFO_0800275
Disease	middle cerebral artery infarction (biomarker_via_orthology)	ERCC6 APAF1 IL1B IL4	8.69e-04	93	134	4	DOID:3525 (biomarker_via_orthology)
Disease	forced expiratory volume, body mass index	DIS3L2 HECTD4	1.10e-03	11	134	2	EFO_0004314, EFO_0004340
Disease	colon cancer (implicated_via_orthology)	NANOGP8 NANOG	1.10e-03	11	134	2	DOID:219 (implicated_via_orthology)
Disease	quality of life during menstruation measurement, dysmenorrheic pain measurement	IL1B VPS13B	1.10e-03	11	134	2	EFO_0007889, EFO_0009366
Disease	unipolar depression	CASP8AP2 CACNA2D1 HIVEP2 DYNC2H1 ABCA13 ASH1L ADGRE2 TRIP11 ZFPM2 DNAJC10 FAM222A ASTN1 ASCC3 SNRNP200	1.20e-03	1206	134	14	EFO_0003761
Disease	Malignant neoplasm of breast	FLT1 ERCC6 ATP7B GFRAL DYNC2H1 SLCO1B1 CNTN6 RGL1 ZNF644 AFF1 IL1B VPS13B GOLGB1	1.24e-03	1074	134	13	C0006142
Disease	rhinitis (biomarker_via_orthology)	IL1B IL4	1.55e-03	13	134	2	DOID:4483 (biomarker_via_orthology)
Disease	peptide measurement	FLT1 ABCA13 KANK1 DLC1	1.57e-03	109	134	4	EFO_0010520
Disease	Kawasaki disease (is_marker_for)	FLT1 IL1B	1.80e-03	14	134	2	DOID:13378 (is_marker_for)
Disease	tetralogy of Fallot (implicated_via_orthology)	DOCK1 ZFPM2	1.80e-03	14	134	2	DOID:6419 (implicated_via_orthology)
Disease	myopia (is_implicated_in)	ZNF644 CPSF1	2.36e-03	16	134	2	DOID:11830 (is_implicated_in)
Disease	response to methotrexate	SLCO1B1 COMMD9	2.36e-03	16	134	2	GO_0031427
Disease	allergic rhinitis (is_marker_for)	IL1B IL4	2.66e-03	17	134	2	DOID:4481 (is_marker_for)
Disease	tea consumption measurement	ZNF618 HECTD4 FAM222A SLC35D3	2.89e-03	129	134	4	EFO_0010091
Disease	cystitis (biomarker_via_orthology)	IL1B IL4	2.99e-03	18	134	2	DOID:1679 (biomarker_via_orthology)
Disease	Benign Neoplasm	DLC1 DNAJC10 IL1B	3.70e-03	68	134	3	C0086692
Disease	Neoplasms	DLC1 DNAJC10 IL1B	3.70e-03	68	134	3	C0027651
Disease	mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement	PPP1R21 TECRL CREB3L4 ADD2 DLC1 IL4	3.94e-03	328	134	6	EFO_0008377, EFO_0008378
Disease	Malignant neoplasm of liver	ATP7B MYO5B ASH1L PTPRO	4.07e-03	142	134	4	C0345904
Disease	Liver neoplasms	ATP7B MYO5B ASH1L PTPRO	4.07e-03	142	134	4	C0023903
Disease	stomach cancer (is_implicated_in)	ERCC6 LRP1B IL1B	4.35e-03	72	134	3	DOID:10534 (is_implicated_in)
Disease	ceramide measurement	BBS2 CREB3L4 SLCO1B1 SUSD1 CREB3	4.46e-03	235	134	5	EFO_0010222

Protein segments in the cluster

Peptide	Gene	Start	Entry
KIQLSENICDSTSSA	ANKRD20A1	396	Q5TYW2
IKAQATTVKSLSQCV	NAIP	1336	Q13075
QSQILASLQSCESSK	AGAP4	416	Q96P64
SQCQILLTTRDKSVT	APAF1	256	O14727
DCKTSTCNSVNLTIL	ERV3-1	191	Q14264
VCNTSVLSSSLQSLE	FAM222A	396	Q5U5X8
TSLQCDTTEKLRNTL	DCUN1D4	166	Q92564
NNSISLLSEKLTSSC	ASH1L	1776	Q9NR48
LKINSSTIEATSNCT	CFAP54	1831	Q96N23
KIQLSENICDSTSSA	ANKRD20A8P	396	Q5CZ79
LTFLLCKAIQNTSTS	ADGRE2	556	Q9UHX3
SSSITKCDTDIQKIL	ACTRT2	281	Q8TDY3
ASSVSVVLSSLQLKC	ATP7B	1361	P35670
LNTLSSLTVNISSCV	ABCA12	911	Q86UK0
KIQLSENICDSTSSA	ANKRD20A4P	396	Q4UJ75
STIEAELNSSLTLQC	CEACAM20	361	Q6UY09
VTVTVLSRKLCNSQS	GZMK	171	P49863
ALVLSCLDQKTIQTV	CFAP46	2696	Q8IYW2
QLNCESLSKNLSSTL	ABCA13	2996	Q86UQ4
LTASLQCNSTAQTEK	CGGBP1	86	Q9UFW8
ESQKQCETLSSKLAT	CD72	256	P21854
CISQDTRALSEKSLQ	DIS3L2	216	Q8IYB7
SVTTLQKNLCDIIES	CASP8AP2	1091	Q9UKL3
SLQCLNETLTSCTKE	DNAJC2	391	Q99543
TLTALTTSVLKNNLC	CD81	161	P60033
TSCTTSLRQINKIIE	ERCC6	141	Q03468
CQQLLASTSVESLLS	ASTE1	581	Q2TB18
VNKTTLTLISITSCV	ASTN1	381	O14525
LSDKCNTVTINLSRD	ATG2B	1291	Q96BY7
QSQILASLQSCESSK	AGAP6	416	Q5VW22
SESKCNLLLSSVSIA	RAB3GAP1	141	Q15042
SQFNTLTKCVVSTIL	RGL1	281	Q9NZL6
KIQSVCLNVSSTLQS	INTS7	846	Q9NVH2
KIQLSENICDSTSSA	ANKRD20A2P	396	Q5SQ80
TSCTTSLRQINKIIE	ERCC6	141	P0DP91
KQNSSLSEIILISCE	PAXIP1	1016	Q6ZW49
SLNCTLRDSQQKSLV	IL1B	121	P01584
VCLNSLKASVQVTTI	KIAA0100	351	Q14667
TDKNSLSSLDCLSNI	MYF5	196	P13349
TCKQEQTTETTSCLL	IL17RD	246	Q8NFM7
ESRESSNQLKCIQIT	LRP1B	251	Q9NZR2
ATVDTQLCDKLLTSS	PPFIBP1	446	Q86W92
CRSLASVLTTNKTLE	NLRP11	906	P59045
TIQSHKEQCTLLTSE	GOLGA4	301	Q13439
LQTSCINSSTVLDLI	ZFPM2	621	Q8WW38
DTCSIVAISLNITQK	CPSF1	236	Q10570
ISLANSVVLCTLTLN	OR2W1	151	Q9Y3N9
CLASSLQLTETQVKT	HMX2	181	A2RU54
ATSILEENQALCTIT	GCLC	131	P48506
CESLKTDLSIQTRNA	DNAH12	241	Q6ZR08
SSSQTVTQIIKCLAN	HEATR6	531	Q6AI08
QKTRTVFSSTQLCVL	NANOG	96	Q9H9S0
TSLKVLTITNCVLLE	PRAMEF15	296	P0DUQ1
TNTCLSTLDKQTSTQ	KANK1	696	Q14678
KDLSTSISVSNCQIQ	PRKD3	551	O94806
EITKITQTIESCLLS	KNTC1	1666	P50748
LSLIKLTCSDTSLNE	OR13H1	181	Q8NG92
KLITTNDCILSSVVA	PPP1R21	461	Q6ZMI0
IDCRKTSQASDTLTI	HECTD4	1781	Q9Y4D8
VALSTEKNCILQTLS	KIZ	421	Q2M2Z5
DLSTATCEKLNLQTS	ITGA2	86	P17301
NSTIVSVVSLTCQKQ	PTPRO	461	Q16827
ATVCLTIQKSSLDQL	ITGAD	651	Q13349
SVSKLSCDDITLNQS	OR56A5	186	P0C7T3
TQQHCITDNSLSLKT	NPIPB11	251	E5RHQ5
SVTSSCFVQNTLTKL	BAGE3	76	Q86Y29
KLLDVTCSSLSVTQE	COMMD9	41	Q9P000
QTTSRHLLQKLSQTC	DYNC2H1	2321	Q8NCM8
KIQLSENICDSTSSA	ANKRD20A3P	396	Q5VUR7
KSLSIISTRSNCINV	EYA4	531	O95677
KTLNSLTEQKTLCTE	IL4	36	P05112
LTEQKTLCTELTVTD	IL4	41	P05112
KNTSQLTQCSLETLS	ICE1	1246	Q9Y2F5
LTQCSLETLSEVLTK	ICE1	1251	Q9Y2F5
VSLLSINQAVSCLTA	BBS2	66	Q9BXC9
SFQISTLVCSTKLTQ	DOCK1	601	Q14185
TLVCSTKLTQNVDLL	DOCK1	606	Q14185
SISTLVCSTKLTQNV	DOCK2	601	Q92608
QIATLICSTKLTQNV	DOCK5	621	Q9H7D0
CNSKLSSIRTEASQL	DOCK9	1486	Q9BZ29
ENCISTLSKQDLTCS	GFRAL	256	Q6UXV0
LITCNDSQESSKLSS	CCDC18	471	Q5T9S5
TASLSKQSCITEQTQ	CACNA2D1	966	P54289
KILSLTETIECLQTN	CDR2	111	Q01850
SLESVSATCKQLSQE	CEP63	356	Q96MT8
SCDIIISTAQILENS	IFIH1	406	Q9BYX4
SKILLTCSLNDSATE	BSG	151	P35613
QSQILASLQSCESSK	AGAP7P	416	Q5VUJ5
LCTVQTTLESLSAVA	CNTN6	576	Q9UQ52
ITCDSKNLTIKTEST	FABP5P3	11	A8MUU1
TQDNLCKSLDITTST	DNAJC10	296	Q8IXB1
LAQKIANTLACSSSS	CES3	271	Q6UWW8
SETLDQSTQLTATCL	FDXACB1	21	Q9BRP7
SVTSSCFVQNTLTKL	BAGE2	76	Q86Y30
SNKTSSSSTCILVLL	CREB3	221	O43889
SLKVLTITNCVLLES	PRAMEF26	201	H0Y7S4
QTSNKAAQTSTCVLI	CREB3L4	286	Q8TEY5
NNILEECTVLKSLSS	MAP3K19	431	Q56UN5
SVLLLEQISSLCSKV	MTBP	336	Q96DY7
TLCSQKAVLIAESTQ	NUP210L	86	Q5VU65
TSTLLKLACSNTQVN	OR1E3	181	Q8WZA6
KLSCIDTTVNEILTL	OR10J1	196	P30954
SGLITSLIQCSLTVQ	OR2G6	151	Q5TZ20
LSHCQTTKIISQTLS	FER1L6	856	Q2WGJ9
ATNSELVGTLIQSCK	TAF4B	636	Q92750
LTLVQCLTSSTAALS	SLC35D3	41	Q5M8T2
RSLCNSIISLNTTIS	TMEM179B	126	Q7Z7N9
ILEQLSCSITQLSKV	TDRD6	1011	O60522
AQLSQTVQSRLVSCK	PPP4R4	181	Q6NUP7
LAALQTLCSSSISKQ	TMEM120B	36	A0PK00
ECLESRVTNQTLTKS	TAGAP	386	Q8N103
RCKVQSSTLVSSLEA	NIN	1646	Q8N4C6
QKTRTVFSSTQLCVL	NANOGP8	96	Q6NSW7
KQQCTIDSLQSSLDS	MYH15	1601	Q9Y2K3
STVLQSELESCKELQ	RABGGTA	361	Q92696
TVCSATSSQKASLLL	FYB2	101	Q5VWT5
TSISSCKTSLQRVQL	SMG1	3181	Q96Q15
TSLKVLTITNCVLLE	PRAMEF25	296	A6NGN4
CTVTQSKSNLTVLKT	SPATA31D4	306	Q6ZUB0
LQISSIKSDNVTRAC	NIT2	11	Q9NQR4
TSLKVLTITNCVLLE	PRAMEF27	296	A3QJZ7
STVTLTQCSEKLVQL	DRG2	191	P55039
SISKSLELCNEISLS	DLC1	186	Q96QB1
TSTLSTCLINQILSL	SLCO1B1	136	Q9Y6L6
SCSEVTASSLIKVNI	ADD2	176	P35612
LSTNVCTLALNSSLV	AFF1	1176	P51825
VNCKVQVLIATSTLA	ASCC3	1636	Q8N3C0
SERKLQSSIQDLCVT	NCAPG2	136	Q86XI2
LSTTLQTIATKLCRE	CLEC12A	106	Q5QGZ9
CTVTQSKSNLTVLKT	SPATA31D3	306	P0C874
SACALNSVVQSVLSK	ZNF618	636	Q5T7W0
VIQCSKLLSDTSVIQ	VPS35L	211	Q7Z3J2
SQKQTVLASRCSAEL	SPATA31D1	1101	Q6ZQQ2
TLTCTEILTKINDVS	SUSD1	291	Q6UWL2
TSLKVLTITNCVLLE	PRAMEF9	296	P0DUQ2
SISSCNKLITSDKVE	WAPL	156	Q7Z5K2
TSLKVLTITNCVLLE	PRAMEF11	296	O60813
CNVTSSSENVIKCIL	PKHD1L1	1371	Q86WI1
IQDLKTCIASTTQTI	USP28	556	Q96RU2
SCSTLKVAADLQLST	ZNF644	151	Q9H582
QTLSDLEQSKCISIE	SNRNP200	1791	O75643
LSQKCQTLLAVLQTS	TRIP11	1176	Q15643
CTSTLAVTSQKLLAT	VPS13B	1181	Q7Z7G8
LSSCANVLELTRTKQ	TRUB1	266	Q8WWH5
ISDLENCLSSVKITS	PLEKHG7	241	Q6ZR37
TTCEQVQGTSDLSKL	SLC9C2	1071	Q5TAH2
KQICILDKVTQSSTI	TECRL	71	Q5HYJ1
VVKLSTSRAVSCLNQ	WDR24	696	Q96S15
TSDKSNLELITLTCT	FLT1	751	P17948
IQTCTKAIASLRIAT	HIVEP2	2326	P31629
LLKLEQNTCSVITTL	WDFY1	181	Q8IWB7
TITTKNLALSSRCLQ	VPS54	801	Q9P1Q0
EKNTLSIQLCDTSQS	GOLGB1	3061	Q14789
SVTSLIQKSSIEKCS	KLRB1	61	Q12918
QVCSLISSDKLTISS	KLHL2	201	O95198
IDSVKKQCSSLQTAI	KRT75	381	O95678
CSLCTSLSTQQIVKI	MYO5B	1761	Q9ULV0
TLLTDSATTAKELCN	MYO7A	1271	Q13402